[go: up one dir, main page]

BR0014979A - Composição hormonal e sua utilização - Google Patents

Composição hormonal e sua utilização

Info

Publication number
BR0014979A
BR0014979A BR0014979-9A BR0014979A BR0014979A BR 0014979 A BR0014979 A BR 0014979A BR 0014979 A BR0014979 A BR 0014979A BR 0014979 A BR0014979 A BR 0014979A
Authority
BR
Brazil
Prior art keywords
estrogenic
hormonal
stroprogestative
progestative
mixture
Prior art date
Application number
BR0014979-9A
Other languages
English (en)
Other versions
BRPI0014979B8 (pt
BRPI0014979B1 (pt
Inventor
Jacques Paris
Jean-Louis Thomas
Original Assignee
Theramex
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Theramex filed Critical Theramex
Publication of BR0014979A publication Critical patent/BR0014979A/pt
Publication of BRPI0014979B1 publication Critical patent/BRPI0014979B1/pt
Publication of BRPI0014979B8 publication Critical patent/BRPI0014979B8/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/32—Antioestrogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Reproductive Health (AREA)
  • Rheumatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)

Abstract

"COMPOSIçãO HORMONAL E SUA UTILIZAçãO". A presente invenção se refere ao campo da química terapêutica e, mais particularmente, ao campo da técnica farmacêutica. Tem mais precisamente por objeto novas composições farmacêuticas hormonais formadas por uma associação estroprogestativa constituída por um composto estrogênico e um composto progestativo, em associação ou em mistura com um ou mais excipientes não tóxicos, inertes e farmaceuticamente aceitáveis, destinadas à administração por via oral. A presente invenção também se refere à utilização da mistura estroprogestativa, em que o componente estrogênico e o componente progestativo são administrados de maneira combinada. A associação combinada pode ser prescrita de maneira contínua ou intermitente, com vistas à realização de uma composição destinada a tratar carências estrogênicas, prevenir osteoporose e doenças cardiovasculares em mulheres na menopausa. A invenção também tem por objeto um processo de preparação dessas novas composições farmacêuticas estroprogestativas.
BRPI0014979A 1999-10-25 2000-10-24 composição hormonal e sua utilização BRPI0014979B8 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/FR1999/002588 WO2001030356A1 (fr) 1999-10-25 1999-10-25 Composition hormonale a base d'un progestatif et d'un estrogene et son utilisation
PCT/FR2000/002939 WO2001030357A1 (fr) 1999-10-25 2000-10-24 Composition hormonale a base d'un progestatif et d'un estrogene et son utilisation

Publications (3)

Publication Number Publication Date
BR0014979A true BR0014979A (pt) 2002-11-26
BRPI0014979B1 BRPI0014979B1 (pt) 2016-08-02
BRPI0014979B8 BRPI0014979B8 (pt) 2021-05-25

Family

ID=9542727

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0014979A BRPI0014979B8 (pt) 1999-10-25 2000-10-24 composição hormonal e sua utilização

Country Status (27)

Country Link
US (2) US8168619B1 (pt)
EP (1) EP1227814B1 (pt)
JP (1) JP5036943B2 (pt)
KR (1) KR100623788B1 (pt)
CN (1) CN100553637C (pt)
AP (1) AP1625A (pt)
AT (1) ATE286400T1 (pt)
AU (1) AU777704B2 (pt)
BR (1) BRPI0014979B8 (pt)
CA (1) CA2389025C (pt)
CZ (1) CZ303248B6 (pt)
DE (1) DE60017281T2 (pt)
DK (1) DK1227814T3 (pt)
ES (1) ES2235967T3 (pt)
HK (1) HK1050472B (pt)
HU (1) HU229382B1 (pt)
IL (2) IL148953A0 (pt)
MX (1) MXPA02004084A (pt)
NO (1) NO327973B1 (pt)
NZ (1) NZ518145A (pt)
OA (1) OA12072A (pt)
PL (1) PL199848B1 (pt)
PT (1) PT1227814E (pt)
RU (1) RU2261106C2 (pt)
SI (1) SI1227814T1 (pt)
WO (2) WO2001030356A1 (pt)
ZA (1) ZA200203398B (pt)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2754179B1 (fr) 1996-10-08 1998-12-24 Theramex Nouvelle composition hormononale et son utilisation
WO2001030356A1 (fr) 1999-10-25 2001-05-03 Laboratoire Theramex Composition hormonale a base d'un progestatif et d'un estrogene et son utilisation
FR2814074B1 (fr) * 2000-09-15 2003-03-07 Theramex Nouvelles compositions estro-progestatives topiques a effet systemique
WO2002094276A1 (en) 2001-05-18 2002-11-28 Pantarhei Bioscience B.V. Pharmaceutical composition for use in hormone replacement therapy
ES2296943T3 (es) 2001-05-23 2008-05-01 Pantarhei Bioscience B.V. Sistema de administracion de un medicamento estrogeno tetrahidroxilado destinado a la contracepcion hormonal.
EP1390041B1 (en) 2001-05-23 2009-11-25 Pantarhei Bioscience B.V. Drug delivery system comprising a tetrahydroxylated estrogen for use in hormonal contraception
ES2278925T3 (es) * 2001-11-15 2007-08-16 Pantarhei Bioscience B.V. Uso de compuestos estrogenicos en combinacion con compuestos progestogenicos en terapias de sustitucion hormonal.
WO2003103685A1 (en) 2002-06-11 2003-12-18 Pantarhei Bioscience B.V. A method of treating human skin and a skin care composition for use in such a method
SI1511496T1 (sl) 2002-06-11 2007-04-30 Pantarhei Bioscience Bv Metoda zdravljenja ali prevencije imunsko mediiranih motenj in farmacevtska formulacija za njeno uporabo
US7192956B2 (en) * 2002-06-25 2007-03-20 Wyeth Methods of treating hormone-related conditions using cyclothiocarbamate derivatives
CA2492287C (en) 2002-07-12 2011-12-13 Pantarhei Bioscience B.V. Pharmaceutical composition comprising estetrol derivatives for use in cancer therapy
SI1556058T1 (sl) 2002-10-23 2008-02-29 Pantarhei Bioscience Bv Farmacevtski sestavki, ki obsegajo estetrolne derivate, za uporabo pri zdravljenju raka
DE602008001783D1 (de) 2007-01-08 2010-08-26 Pantarhei Bioscience Bv Verfahren zur behandlung oder prävention von unfruchtbarkeit bei weiblichen säugern und pharmazeutisches kit zur anwendung dieses verfahrens
CN107007611B (zh) * 2017-06-02 2020-04-14 上海市计划生育科学研究所 醋酸诺美孕酮在制备治疗子宫内膜癌的药物中的应用

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4826831A (en) 1983-08-05 1989-05-02 Pre Jay Holdings Limited Method of hormonal treatment for menopausal or post-menopausal disorders involving continuous administration of progestogens and estrogens
JPS61243059A (ja) 1985-04-19 1986-10-29 Konishi Kagaku Kogyo Kk 高純度４，４′−ジヒドロキシジフエニルスルホンの製造法
DE3603644A1 (de) 1986-02-06 1987-08-13 Metabowerke Kg Spannfutter zum einspannen von bohrern oder schlagbohrern
US5208225A (en) * 1986-02-27 1993-05-04 Warner-Lambert Company Compositions containing fixed combinations
ZA87332B (en) 1986-02-27 1987-08-26 Warner Lambert Co Compositions containing fixed combinations
US5276022A (en) 1987-09-24 1994-01-04 Jencap Research Ltd. Hormone preparation and method
US5256421A (en) 1987-09-24 1993-10-26 Jencap Research Ltd. Hormone preparation and method
US5108995A (en) 1987-09-24 1992-04-28 Jencap Research Ltd. Hormone preparation and method
ES2169030T3 (es) 1987-09-24 2002-07-01 Jencap Res Ltd Envases de anticonceptivos que contienen estrogeno y progestina.
CA1332227C (en) 1987-09-24 1994-10-04 Robert F. Casper Oral contraceptive formulation
HUT52382A (en) 1988-03-14 1990-07-28 Sandoz Ag Process for producing pharmaceutical compositions comprising as active ingredient unsubstituted progestin in 19-position and estrogen in the given case
IE71203B1 (en) 1990-12-13 1997-02-12 Akzo Nv Low estrogen oral contraceptives
FR2695826B1 (fr) 1992-09-21 1995-01-06 Theramex Nouvelles compositions pharmaceutiques à base de dérivés de nomégestrol et leurs procédés d'obtention.
US5554601A (en) 1993-11-05 1996-09-10 University Of Florida Methods for neuroprotection
US5552394A (en) 1994-07-22 1996-09-03 The Medical College Of Hampton Roads Low dose oral contraceptives with less breakthrough bleeding and sustained efficacy
US6613757B1 (en) 1994-09-22 2003-09-02 Board Of Regents, The University Of Texas System Combination of prostacyclin with an estrogen or progestin for the prevention and treatment of atherosclerotic vascular disease including preeclampsia and for the treatment of hypertension, and for hormone replacement therapy
SE9403389D0 (sv) 1994-10-06 1994-10-06 Astra Ab Pharmaceutical composition containing derivattves of sex hormones
FR2737411B1 (fr) 1995-08-01 1997-10-17 Theramex Nouveaux medicaments hormonaux et leur utilisation pour la correction des carences estrogeniques
ATE247971T1 (de) 1995-08-01 2003-09-15 Novartis Erfind Verwalt Gmbh Liposomale oligonukleotidzusammensetzungen
US5888543A (en) 1996-07-26 1999-03-30 American Home Products Corporation Oral contraceptives
FR2754179B1 (fr) 1996-10-08 1998-12-24 Theramex Nouvelle composition hormononale et son utilisation
WO2001030355A1 (fr) 1999-10-25 2001-05-03 Laboratoire Theramex Medicament contraceptif a base d'un progestatif et d'un estrogene et son mode de preparation
DE19739916C2 (de) 1997-09-11 2001-09-13 Hesch Rolf Dieter Verwendung einer Kombination aus einem Gestagen und einem Estrogen zur kontinuierlichen Ovulationshemmung und ggf. gleichzeitigen Behandlung und/oder Prophylaxe von Tumoren der Brustdrüsen
FR2776191B1 (fr) * 1998-03-23 2002-05-31 Theramex Composition hormonale topique a effet systemique
WO2001030356A1 (fr) 1999-10-25 2001-05-03 Laboratoire Theramex Composition hormonale a base d'un progestatif et d'un estrogene et son utilisation
FR2814074B1 (fr) * 2000-09-15 2003-03-07 Theramex Nouvelles compositions estro-progestatives topiques a effet systemique
DE60218881T2 (de) * 2001-11-15 2007-12-20 Pantarhei Bioscience B.V. Verfahren zur vorbeugung oder behandlung von benignen gynäkologischen störungen
AR065816A1 (es) 2007-03-26 2009-07-01 Theramex Regimen anticonceptivo oral

Also Published As

Publication number Publication date
US8168619B1 (en) 2012-05-01
RU2261106C2 (ru) 2005-09-27
PL356847A1 (en) 2004-07-12
JP2003515531A (ja) 2003-05-07
OA12072A (fr) 2006-05-04
CZ303248B6 (cs) 2012-06-20
EP1227814A1 (fr) 2002-08-07
RU2002113652A (ru) 2004-03-27
BRPI0014979B8 (pt) 2021-05-25
IL148953A (en) 2007-06-03
HUP0203721A3 (en) 2003-07-28
NZ518145A (en) 2005-01-28
HUP0203721A2 (hu) 2003-03-28
AP1625A (en) 2006-07-04
EP1227814B1 (fr) 2005-01-05
HK1050472B (zh) 2005-07-08
PT1227814E (pt) 2005-05-31
WO2001030356A1 (fr) 2001-05-03
MXPA02004084A (es) 2003-08-20
AU1032601A (en) 2001-05-08
CA2389025A1 (fr) 2001-05-03
CZ20021427A3 (cs) 2002-08-14
CN1382053A (zh) 2002-11-27
ATE286400T1 (de) 2005-01-15
DE60017281D1 (de) 2005-02-10
DE60017281T2 (de) 2005-12-08
JP5036943B2 (ja) 2012-09-26
KR100623788B1 (ko) 2006-09-18
ZA200203398B (en) 2003-12-03
CN100553637C (zh) 2009-10-28
NO20021949L (no) 2002-04-25
SI1227814T1 (en) 2005-06-30
PL199848B1 (pl) 2008-11-28
US20130172300A1 (en) 2013-07-04
DK1227814T3 (da) 2005-04-11
HK1050472A1 (en) 2003-06-27
NO20021949D0 (no) 2002-04-25
WO2001030357A1 (fr) 2001-05-03
US9084796B2 (en) 2015-07-21
IL148953A0 (en) 2002-11-10
AU777704B2 (en) 2004-10-28
CA2389025C (fr) 2009-12-08
KR20020057979A (ko) 2002-07-12
BRPI0014979B1 (pt) 2016-08-02
ES2235967T3 (es) 2005-07-16
HU229382B1 (hu) 2013-11-28
NO327973B1 (no) 2009-11-02
AP2002002475A0 (en) 2002-06-30

Similar Documents

Publication Publication Date Title
BR0014979A (pt) Composição hormonal e sua utilização
JP5118633B2 (ja) 医療用デバイスおよび医薬製剤において有用な粘膜付着性キシログルカン含有製剤
CA3097278C (en) Compounds and their uses for alleviating menopause-associated symptoms
BR0111186A (pt) Uso de composição de celecoxib para rápido alìvio de dor
BRPI0011867B8 (pt) preparação farmacêutica de levodopa/carbidopa/entacapona e processo para preparação da mesma
BR9911071A (pt) Preparações para aplicação de agentes antiinflamatórios, especialmente anti-sépticos e/ou agentes promotores da cura de feridas no trato respiratório superior e/ou no ouvido
BR0012488A (pt) Composição farmacêutica, métodos para melhorar a taxa de absorção de um ou mais do que um agente farmaceuticamente ativo em mamìferos, para melhorar o inìcio do benefìcio terapêutico de um ou mais do que um agente farmaceuticamente ativo em mamìferos, para inibição de gastroirritação em um mamìfero, e para tratamento de mamìferos necessitando do tratamento proporcionado por um ou mais do que um agente farmaceuticamente ativo, e, processo para preparar uma composição farmacêutica
BR0109334A (pt) Terapia de reposição hormonal
BRPI0410786A (pt) composição, uso da mesma, e, método de tratamento de um distúrbio de humor em um paciente
BR9914419A (pt) Terapia para melhoria da percepção
HUP0700038A2 (en) Use of (3r,4r)-delta8-tetrahydrocannabinol-11-oic acids for the preparation of medicines for decreasing cell proliferation
BR9712274A (pt) Composição hormonal consistindo de um composto de estrogênio e um composto progestacional
AP1849A (en) Dosage regimen and pharmaceutical composition for emergency contraception
BR9908431A (pt) Cloridrato de fluoxetina para diminuição de fogalhos
KR970061244A (ko) 치매 치료용 약학 조성물
BR0313494A (pt) Métodos de administração e realce da absorção de agentes farmacêuticos
IL120558A (en) Hormonal drugs and their uses for repairing estrogen deficiencies
MXPA04012410A (es) Composiciones, formulaciones y equipo para el tratamiento de enfermedades pulmonares y respiratorias con deshidroepiandrosteronas, esteroides y agentes antimuscarinicos.
BR0014952A (pt) Medicamento contraceptivo e seu modo de preparação
BR0205104A (pt) Composição hormonal inédita e sua utilização
BG107042A (bg) Двойни инхибитори на синтезата на холестеролов естер и восъчен естер, за лечение на разсройства на мастната жлеза
BR0115506A (pt) Composições farmacêuticas tendo uma ação antidiabética, e processo para sua preparação
JP2005511768A (ja) エストロゲン及び他のホルモンとアスコルベート、リジン、プロリン及び他の物質との組成物
BR0011094A (pt) Polimorfos de um citrato cristalino de azobiciclo[2,2,2]octan-3-amina e suas composições farmacêuticas
US20060198914A1 (en) Use of rutin and isoharmnetin for treating depressive states and depression and other emotion disorders

Legal Events

Date Code Title Description
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]

Free format text: DE ACORDO COM ART. 34 " II " DA LPI ( LEI 9279, DE 14/05/96 ), O EXAME FICA SUSPENSO PARA QUE O REQUERENTE APRESENTE DOCUMENTOS NECESSARIOS A REGULARIZACAO DO PROCESSO E EXAME DO PEDIDO.

B11E Dismissal acc. art. 34 of ipl - requirements for examination incomplete
B11N Dismissal: publication cancelled [chapter 11.14 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 02/08/2016, OBSERVADAS AS CONDICOES LEGAIS.

B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 24/10/2000 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF

B21A Patent or certificate of addition expired [chapter 21.1 patent gazette]

Free format text: PATENTE EXTINTA EM 24/10/2020